Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Regeneron seals $450m BARDA contract to scale up production of its COVID-19 vaccine

July 9, 2020 Manufacturing and Production, Sales and Marketing BARDA, Operation Warp Speed, Regeneron, US, vaccine COVID-19

Regeneron has revealed that REGN-COV2, its two-antibody vaccine for the treatment and prevention of COVID-19, has been awarded a manufacturing …
News

European green light for Lynparza in germline BRCA-mutated metastatic pancreatic cancer

July 8, 2020 Research and Development, Sales and Marketing AstraZeneca, Cancer, Europe, MSD, lynparza

The European Commission has awarded approval to AstraZeneca and MSD’s Lynparza (olaparib) for germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer, with …
News

Tesla to offer “microfactories” to scale up production of CureVac’s potential COVID-19 vaccine

July 6, 2020 Manufacturing and Production, Sales and Marketing COVID-19, CureVac, Vaccine, tesla

Electric car firm Tesla has announced it will be supplying mobile molecular printer capacity to German firm CureVac, and possibly …
News

ViiV Healthcare secures FDA approval for Rukobia combo in multidrug-resistant HIV-1

July 6, 2020 Sales and Marketing FDA, HIV, ViiV Healthcare

ViiV Healthcare, the HIV specialist majority owned by GSK which also counts Shionogi and Pfizer among its shareholders, has secured …
News

US moving remdesivir supplies to COVID-19 hotspots

July 6, 2020 Sales and Marketing Arizona, COVID, states, texas

The US government is sending significant remdesivir supplies to states that are being hit hardest by the coronavirus. Florida, Arizona …
News

Florida issues warning over ‘brain-eating’ amoeba

July 6, 2020 Sales and Marketing amoeba, infection, lakes

The Florida Department of Health has issued a warning over a rare case of ‘brain-eating’ amoeba after one person has …
News

WHO halt coronavirus trials of hydroxychloroquine, lopinavir and ritonavir

July 6, 2020 Sales and Marketing COVID, COVID-19, WHO, coronavirus

The World Health Organization has discontinued trials into the viability of hydroxychloroquine, lopinavir and ritonavir as COVID-19 treatments. This was …
News

Top Ten most popular articles on Pharmafile.com this week

July 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronaviurs, top 10

Gilead features prominently in the news this week, as the US bought most of the world’s stock of the company’s …
News

UK Government accused of withholding Pillar 2 COVID-19 data which show Leicester had 10 times more cases than reported pre-lockdown

July 1, 2020 Medical Communications, Research and Development, Sales and Marketing COVID-19, UK

The UK Government warned when relaxing lockdown measures on 23 June that it would not hesitate to lock down any …
News

FDA approves Pfizer and Merck KGaA’s Bavencio for maintenance of advanced bladder cancer

July 1, 2020 Research and Development, Sales and Marketing Bavencio FDA, EMD Serono, Merck, Pfier

The FDA has moved to approve Bavencio (avelumab), developed by Pfizer and EMD Serono, the biopharma arm of Merck KGaA, …
News

Roche’s Phesgo combo secures US approval for metastatic HER2-positive breast cancer

June 30, 2020 Manufacturing and Production, Sales and Marketing FDA, Phesgo, Roche, US, breast cancer

The FDA has awarded marketing authorisation in the US to Roche’s Phesgo, a combination of subcutaneously injected Herceptin (trastuzumab) with …
News

The July/August 2020 issue of Pharmafocus is available to read free online now!

June 30, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Pharmafocus, pharma

The July/August 2020 issue of Pharmafocus is available to read free online now!
News

NICE knocks back Janssen’s Zytiga combo for newly diagnosed, hormone-sensitive metastatic prostate cancer.

June 29, 2020 Sales and Marketing

Drug watchdog NICE has chosen to stick with its earlier decision not to recommend Janssen’s Zytiga (abiraterone aetate), combined with …
News

FDA rejects Allergan’s Abicipar pegol for neovascular age-related macular degeneration over benefit/risk concerns

June 29, 2020 Sales and Marketing AbbVie, Allergan, FDA, pharma

The FDA has moved to reject Allergan’s vascular endothelial growth factor (VEGF) factor A inhibitor, Abicipar pegol, as treatment for …
News

Vaxart announces its COVID-19 vaccine has been selected by US Operation Warp Speed programme

June 29, 2020 Sales and Marketing COVID-19, COVID-19 vaccine, coronavirus, coronavirus vaccine

Vaxart has announced the selection of its lead vaccine candidate for COVID-19 by Operation Warp Speed, a program to find …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026